BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10701067)

  • 21. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
    Esterre P; Volney B; Meynard JB; Legrand E
    Bull Soc Pathol Exot; 2009 Aug; 102(3):179-84. PubMed ID: 19739416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cyclines and malaria].
    Briolant S; Almeras L; Fusai T; Rogier C; Pradines B
    Med Trop (Mars); 2007 Feb; 67(1):86-96. PubMed ID: 17506281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Discussion on strategy of imported falciparum malaria control in Baoying County, 2007 -2009].
    Lu JX; Zheng B; Liu GX
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Feb; 23(1):64, 78. PubMed ID: 22164378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imported malaria in children: a national surveillance in the Netherlands and a review of European studies.
    Driessen GJ; Pereira RR; Brabin BJ; Hartwig NG
    Eur J Public Health; 2008 Apr; 18(2):184-8. PubMed ID: 17984130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Imported malaria at the Marseilles Hôpital-Nord, France: a prospective study on 352 cases between 2001 and 2003].
    Parola P; Minodier P; Soula G; Jaffré Y; Badiaga S; Retornaz K; Garnier JM; Delmont J; Parzy D; Brouqui P
    Med Mal Infect; 2005 Oct; 35(10):482-8. PubMed ID: 16271842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.
    Parola P; Pradines B; Simon F; Carlotti MP; Minodier P; Ranjeva MP; Badiaga S; Bertaux L; Delmont J; Morillon M; Silai R; Brouqui P; Parzy D
    Am J Trop Med Hyg; 2007 Sep; 77(3):431-7. PubMed ID: 17827355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems in the therapy for imported malaria in the United States.
    Singh K; Wester WC; Trenholme GM
    Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malaria treatment in children. 2. Severe malaria].
    Imbert P; Gendrel D
    Med Trop (Mars); 2002; 62(6):657-64. PubMed ID: 12731315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
    Price RN; Nosten F
    Drug Resist Updat; 2001 Jun; 4(3):187-96. PubMed ID: 11768332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Travellers returning to Sweden with falciparum malaria: pre-travel advice, behaviour, chemoprophylaxis and diagnostic delay.
    Askling HH; Ekdahl K; Janzon R; Henric Braconier J; Bronner U; Hellgren U; Rombo L; Tegnell A
    Scand J Infect Dis; 2005; 37(10):760-5. PubMed ID: 16191897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management and prevention of imported Plasmodium falciparum malaria (Revision 2007 of the 1999 Consensus Conference). Long text in French].
    ; ; ; ; ; ; ;
    Med Mal Infect; 2008 Feb; 38(2):68-117. PubMed ID: 18646361
    [No Abstract]   [Full Text] [Related]  

  • 35. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
    Nzila A
    J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium falciparum in vivo resistance to quinine: description of two RIII responses in French Guiana.
    Demar M; Carme B
    Am J Trop Med Hyg; 2004 Feb; 70(2):125-7. PubMed ID: 14993621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A plasmodium alciparum malaria case originated from Mozambique: clues for the diagnosis and therapy].
    Ozkaya G; Yildirim T; Aydin K; Ergüven S; Unal S
    Mikrobiyol Bul; 2006 Oct; 40(4):407-11. PubMed ID: 17205701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prevention of traveler's malaria: current findings].
    Gianzi FP; Majori G; Franco E; Panà A
    Ann Ig; 1992; 4(6):369-81. PubMed ID: 1285078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.